Biopharmaceutical Contract Manufacturing Market: By Manufacturing Process, By Type Of Service, By Molecule Type, By End-User and Geography.

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Biopharmaceutical Contract Manufacturing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Manufacturing Process (Mammalian Based, Microbial Based, Insect Based, Plant Based, Yeast Based, Others), By Type Of Service (Formulation, Fill and Finish Services, Cell Banking, Analytical Services, Process development, Others), By Molecule Type (Large Molecules, Small Molecules), By End-User (Biopharmaceutical Companies, Pharmaceutical Companies, Research Organizations, Others) and Region.

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Biopharmaceutical contract manufacturing market size was valued at US$ 16.2 billion in 2022 and is expected to reach US$ 23.57 billion by 2029 at a CAGR of 5.5% from 2023 to 2029. Biopharmaceuticals are also known as biologics. Biopharmaceutical products are pharmaceutical drugs that are synthesized, processed, or extracted from biological sources. Biopharmaceuticals include vaccines, blood products, recombinant therapeutic proteins, allergens, gene therapies, tissues, and living cells used in cell therapy. Many companies outsource the manufacturing of biopharmaceuticals due to a lack of manufacturing capabilities or in order to reduce the cost of the manufacturing process.

Contract manufacturing organizations offer a wide range of services such as cell line development, process optimization, fermentation biotechnology, analytical characterization, cGMP manufacturing, and validation in each stage of clinical development and commercialization. Furthermore, to meet the demand for biological products, companies are outsourcing biopharmaceutical manufacturing to various contract manufacturing companies. However, high cost associated with manufacturing and stringent regulatory requirements are expected to hamper the growth of the biopharmaceutical contract manufacturing market. The market is highly competitive where the speed to market is imperative along with efficient processes and low costs. Biopharmaceutical contract manufacturing services providers are increasing their service offerings such as formulation, production, and analytical services apart from conventional services to provide complete support for biopharmaceutical companies. Cost considerations and quick services are expected to continue to drive the outsourcing of the global biopharmaceutical contract manufacturing market.

Biopharmaceutical Contract Manufacturing Market Key Developments:

  • In May 2017, Lonza Group Ltd. acquired cell and gene contract manufacturer PharmaCell B.V., this acquisition broadens Lonza's capabilities in Europe region. Companies expand their manufacturing facilities to increase market share.
  • In May 2017, Boehringer Ingelheim GmbH started a new manufacturing facility in China to increase its manufacturing capacity. Through this facility company's manufacturing capacity will increase by one-third.

 

summary download arrow Download Free Sample

Global Biopharmaceutical Contract Manufacturing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.5%

Largest Market

North America

Fastest Growing Market

North America

Biopharmaceutical Contract Manufacturing Market Dynamics

Biopharmaceutical contract manufacturing market is mainly driven by increase in investment of the pharma and biotechnological companies to develop and commercialize the biotechnological products. In addition, high revenue generation of blockbuster biological drugs such as humira, rituxan, lantus, avastin, herceptin and remicade are gaining traction from many biologicsmanufacturers. Advancements in the biotechnology such as recombinant DNA technologies and targeted drug therapies are expected to bolster the biopharmaceutical contract manufacturing market over the forecast period.

Global Biopharmaceutical Contract Manufacturing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2022

US$ 16.2 billion

Market Size in 2029

US$ 23.57 billion

Market CAGR

5.5%

By Manufacturing Process

  • Mammalian Based,
  • Microbial Based,
  • Insect Based,
  • Plant Based,
  • Yeast Based,
  • Others

By Type Of Service

  • Formulation,
  • Fill and Finish Services,
  • Cell Banking,
  • Analytical Services,
  • Process development,
  • Others

By Molecule Type

  • Large Molecules,
  • Small Molecules

By End-User

  • Biopharmaceutical Companies,
  • Pharmaceutical Companies,
  • Research Organizations,
  • Others

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The biopharmaceutical contract manufacturing market key players are: Lonza Group Ltd. (Switzerland), Boehringer Ingelheim GmbH (Germany), Charles River Laboratories, Inc. (U.S), Novartis AG (Switzerland), WuXi AppTec Group (China),Rentschler Biotechnologie GmbH (Germany), Fujifilm Holdings Corporation (Japan), Celonic AG (Switzerland), BIOMEVA GmbH (Germany), ProBioGen AG (Germany)

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

The key segments covered in the biopharmaceutical contract manufacturing market are, by manufacturing process, type of service, molecule type, and end-users.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Biopharmaceutical Contract Manufacturing Market Introduction 
2.1.Global Biopharmaceutical Contract Manufacturing Market  - Taxonomy
2.2.Global Biopharmaceutical Contract Manufacturing Market  - Definitions
2.2.1. Manufacturing Process
2.2.2.Type Of Service
2.2.3.Molecule Type 
2.2.4.End-User
2.2.5.Region
3.Global Biopharmaceutical Contract Manufacturing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Biopharmaceutical Contract Manufacturing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Biopharmaceutical Contract Manufacturing Market  By  Manufacturing Process, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Mammalian Based,
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Microbial Based,
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Insect Based,
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Plant Based,
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Yeast Based,
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Others
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6.Global Biopharmaceutical Contract Manufacturing Market  By Type Of Service, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Formulation,
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Fill and Finish Services,
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Cell Banking,
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Analytical Services,
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Process development,
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Others
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others (Agrochemicals, Pharmaceuticals, and Automotive))
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7.Global Biopharmaceutical Contract Manufacturing Market  By Molecule Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Large Molecules,
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Small Molecules
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
8.Global Biopharmaceutical Contract Manufacturing Market  By End-User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Biopharmaceutical Companies,
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Pharmaceutical Companies,
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Research Organizations,
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9.Global Biopharmaceutical Contract Manufacturing Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Biopharmaceutical Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1.  Manufacturing Process Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Mammalian Based,
10.1.2.Microbial Based,
10.1.3.Insect Based,
10.1.4.Plant Based,
10.1.5.Yeast Based,
10.1.6.Others
10.2.  Type Of Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Formulation,
10.2.2.Fill and Finish Services,
10.2.3.Cell Banking,
10.2.4.Analytical Services,
10.2.5.Process development,
10.2.6.Others
10.2.7.Others (Agrochemicals, Pharmaceuticals, and Automotive))
10.3.  Molecule Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Large Molecules,
10.3.2.Small Molecules
10.4.  End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Biopharmaceutical Companies,
10.4.2.Pharmaceutical Companies,
10.4.3.Research Organizations,
10.4.4.Others
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Biopharmaceutical Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1.  Manufacturing Process Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Mammalian Based,
11.1.2.Microbial Based,
11.1.3.Insect Based,
11.1.4.Plant Based,
11.1.5.Yeast Based,
11.1.6.Others
11.2.  Type Of Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Formulation,
11.2.2.Fill and Finish Services,
11.2.3.Cell Banking,
11.2.4.Analytical Services,
11.2.5.Process development,
11.2.6.Others
11.2.7.Others (Agrochemicals, Pharmaceuticals, and Automotive))
11.3.  Molecule Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Large Molecules,
11.3.2.Small Molecules
11.4.  End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Biopharmaceutical Companies,
11.4.2.Pharmaceutical Companies,
11.4.3.Research Organizations,
11.4.4.Others
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
12.Asia Pacific (APAC) Biopharmaceutical Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1.  Manufacturing Process Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Mammalian Based,
12.1.2.Microbial Based,
12.1.3.Insect Based,
12.1.4.Plant Based,
12.1.5.Yeast Based,
12.1.6.Others
12.2.  Type Of Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Formulation,
12.2.2.Fill and Finish Services,
12.2.3.Cell Banking,
12.2.4.Analytical Services,
12.2.5.Process development,
12.2.6.Others
12.2.7.Others (Agrochemicals, Pharmaceuticals, and Automotive))
12.3.  Molecule Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Large Molecules,
12.3.2.Small Molecules
12.4.  End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Biopharmaceutical Companies,
12.4.2.Pharmaceutical Companies,
12.4.3.Research Organizations,
12.4.4.Others
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Biopharmaceutical Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1.  Manufacturing Process Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Mammalian Based,
13.1.2.Microbial Based,
13.1.3.Insect Based,
13.1.4.Plant Based,
13.1.5.Yeast Based,
13.1.6.Others
13.2.  Type Of Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Formulation,
13.2.2.Fill and Finish Services,
13.2.3.Cell Banking,
13.2.4.Analytical Services,
13.2.5.Process development,
13.2.6.Others
13.2.7.Others (Agrochemicals, Pharmaceuticals, and Automotive))
13.3.  Molecule Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Large Molecules,
13.3.2.Small Molecules
13.4.  End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Biopharmaceutical Companies,
13.4.2.Pharmaceutical Companies,
13.4.3.Research Organizations,
13.4.4.Others
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Biopharmaceutical Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1.  Manufacturing Process Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Mammalian Based,
14.1.2.Microbial Based,
14.1.3.Insect Based,
14.1.4.Plant Based,
14.1.5.Yeast Based,
14.1.6.Others
14.2.  Type Of Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Formulation,
14.2.2.Fill and Finish Services,
14.2.3.Cell Banking,
14.2.4.Analytical Services,
14.2.5.Process development,
14.2.6.Others
14.2.7.Others (Agrochemicals, Pharmaceuticals, and Automotive))
14.3.  Molecule Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Large Molecules,
14.3.2.Small Molecules
14.4.  End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Biopharmaceutical Companies,
14.4.2.Pharmaceutical Companies,
14.4.3.Research Organizations,
14.4.4.Others
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Lonza Group Ltd. (Switzerland)
15.2.2.Boehringer Ingelheim GmbH (Germany)
15.2.3.Charles River Laboratories, Inc. (U.S)
15.2.4.Novartis AG (Switzerland)
15.2.5.WuXi AppTec Group (China)
15.2.6.Rentschler Biotechnologie GmbH (Germany)
15.2.7.Fujifilm Holdings Corporation (Japan)
15.2.8.Celonic AG (Switzerland)
15.2.9.BIOMEVA GmbH (Germany)
15.2.10.ProBioGen AG (Germany)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Lonza Group Ltd. (Switzerland)
  • Boehringer Ingelheim GmbH (Germany)
  • Charles River Laboratories, Inc. (U.S)
  • Novartis AG (Switzerland)
  • WuXi AppTec Group (China)
  • Rentschler Biotechnologie GmbH (Germany)
  • Fujifilm Holdings Corporation (Japan)
  • Celonic AG (Switzerland)
  • BIOMEVA GmbH (Germany)
  • ProBioGen AG (Germany)

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market